Hints and tips:
Related Special Reports
...GSK Listing: London Like many other pharmaceutical companies, GSK generates almost half its sales in the US because of the country’s high drug prices....
...know: business Novo Nordisk announced a €1bn deal for a German biotech developing therapies to treat heart disease, as the Danish group seeks to branch out from its blockbuster diabetes and weight loss drugs...
...Run by former Moelis partner Kasim Kutay, the life sciences investment group is swimming in cash thanks to dividends from the drugs....
...Smart reads OzempicWatchers As WeightWatchers’ stock price languishes, the company is attempting a turnaround that relies on anti-obesity drugs, the FT writes....
...Hernandez is facing drug trafficking charges....
...It uses this to calculate predispositions for ill health while feeding information into a research programme for drug development. So far, however, this vast database has produced little of value....
...People encounter some types of UV light every day, but the US Food and Drug Administration notes online that UVC radiation “can cause severe burns of the skin and eye injuries (photokeratitis)” and advises...
...Wall Street on Ozempic The novel weight loss drug is fuelling wild market predictions, from snack makers pivoting to produce, to airlines saving on fuel because of lighter passengers, The Wall Street Journal...
...In the internal note, a Google executive called search advertising “one of the world’s greatest business models ever created”, before adding that only “illicit businesses (cigarettes or drugs) . . . could...
...Miles’s book “Chasing Shadows: A true story of drugs, war and the secret world of international crime”, will be published by The Bridge Street Press on August 3....
...The FTC’s intervention shocked the industry, which relies on deals to replenish drug pipelines. Small firms originate two-thirds of new active substances....
...Sentiment is one hell of a drug, and it should come as no surprise that venture capital, which has perfected the art of moving entire markets through its echo-chamber hype, has managed to hype its own rumours...
...In the US, Galleri tests are sold as “laboratory-developed” because they have not yet been approved by the US Food and Drug Administration....
...biotechnology firm claimed a “particularly egregious example” of this activity took place in May, after the publication of what they maintain were positive trial data for Northwest’s DCVax-L brain cancer drug...
...Grail is selling Galleri to US consumers for about $950 as a “laboratory-developed test”, a category that does not require approval from the US Food and Drug Administration and is not widely reimbursed by...
...Last Thursday one of Muddy Waters’ Cayman Islands vehicles, MW Domino Management LLC, disclosed a 0.69 per cent short of Pantheon on the FCA register....
...That argues for the implementation of randomised control trials for foundation models before release, she says, just as for pharmaceutical drugs....
...Laboratoire XO, which makes the hypertension drug Loxen, was one of three companies owned by the fund, alongside NSO and the Estonia-based gambling business Olympic Entertainment Group....
...Intellia is more cautious in its pronouncements and will only say its drug “could potentially be the first curative treatment” for the illness....
...The billionaire deputy prime minister of the UAE controls the club via Newton Investment Development LLC, a company registered in Abu Dhabi....
...Its 2020 research using AI to predict how proteins fold into different shapes was heralded as a breakthrough that could lead to advances in fields such as drug discovery....
...P-scores indicate whether a certain drug really does help, or if cheap stocks do outperform over time....
...Another Future Fund investment, the company’s stated mission is to “radically accelerate drug development”. Currently, its website’s main call to action is for prospective applicants to “Join Us”....
...But he applied the same thinking to private companies, where they would say, ‘Next year, we’re going to get this drug authorised and we’ll make billions,’ and he’d say, ‘I’m in for that.’...
...There is even a case for creating the algorithmic equivalent of the US Food and Drug Administration to preapprove the use of AI in sensitive areas....
International Edition